PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Bitscape

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Clinical Trials at UK Done by Veeda Clinical Research - Veeda Clinical Research offers service of Phase I/II Clinical Trials at UK and India - VeedaCR.com
Clinical Trials at UK Done by Veeda Clinical Research

 

NewswireToday - /newswire/ - London, United Kingdom, 2006/03/14 - Veeda Clinical Research offers service of Phase I/II Clinical Trials at UK and India - VeedaCR.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The 15 billion dollar world of Clinical Research has a major new player in its fastest growing sector, that of phase I clinical trials. Veeda Clinical Research.

known as Veeda CR, brings together the highly respected UK CRO Phase 1 CTU Ltd, ClinSearch Labs Pvt. Ltd. of Ahmedabad and Triphasic Clinical Trials
Laboratories a Plymouth, UK based, GLP accredited laboratory. Veeda CR can count many of the world’s top ten Pharmaceutical Companies as clients and sees huge potential in unleashing the synergies of its Indian -European collaboration onto a global market place. Veeda CR’s revenue in India currently stands at 32 crores and is expected to double over the next 12 months. “Veeda CR represents the ideal bridge between cultures – combining vast experience and expertise in handling the most technically complex trials to the most stringent regulatory standards with the massive technical, data management and volunteer capability of the Indian subcontinent” said Director

Mr. Apurva Shah

Veeda CR sees its key attribute as its uncompromising commitment to quality and it will use the recognised expertise of its European personnel to help train its research professionals in India. This will be achieved by a two way traffic between continents with research professionals from India undergoing intensive training in the UK and Western project management skills following European research projects into India.

Dr Kiran Marthak, a Director of Veeda CR, is delighted to have joined the Veeda CR at this exciting juncture. Dr Marthak is a pioneer of clinical research activities in India and brings to Veeda CR experience of working with pharmaceutical majors such as Novartis, German Remedies, Pfizer, and Ranbaxy.

Dr Marthak said “We have managed to combine the best of a top 5 Early Clinical Development Unit in the UK, with all the advantages of a vibrant new unit on the Indian subcontinent, with both Units operating to exactly the same stringent standards set by international regulatory authorities”

Veeda CR has adopted the image of the Bengal Tiger to exemplify its promise to “Unleash the power of India”. Maurice Cross, a Director of Veeda CR’s said “our marketing team was searching for an icon that represented the power, strength and integrity of Veeda and was also indigenous to the Indian sub continent. Our research gave us a number of interesting alternatives but the dignity and overwhelming presence of the Bengal Tiger fit the bill perfectly. When we saw the photograph it simply swept us away, both our UK and Indian colleagues were
unanimous in their enthusiasm for it. We understand Veeda means “knowledge” and our tiger exudes knowledge and wisdom from every pore. It is a wonderful symbol of both India and Veeda CR.”

© 2006 Veeda Clinical Research

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Bitscape

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Clinical Trials at UK Done by Veeda Clinical Research

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: James Watt - VeedaCR.com 
53554566 seo[.]bitscape.co.in
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bitscape securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bitscape / Company Profile


Read Health/Surgery Most Recent Related Newswires:

HPMC Capsules Market to Register 10.9% CAGR During 2017-2025 Finds Persistence Market Research
Persistence Market Research Publishes Blood Thinner Market Opportunities and Forecasts 2017-2025
Occupational Medicine Market Estimated to Expand At A Robust CAGR Over 2025 Notes PMR
Persistence Market Research Publishes Traditional Chinese Medicine Market Forecast Over 2017-2025
Inferior Vena Cava Filters Market to Register A Strong Growth by 2025 Notes Persistence Market Research
Plasma Component Separator Market Set to Surge Significantly During 2017-2025 Says PMR
Persistence Market Research Releases Fertility Enhancing Treatment Market Snapshot by 2017-2025
Disposable Diabetes Devices Market Expected to Generate Huge Profits by 2025 Finds Reports Persistence Market Research
Cardiac Biomarkers Market Expected to Generate Huge Profits by 2017-2025 Reports PMR
Stone Management System Market Foreseen to Grow Exponentially Over 2017-2025 Finds PMR
Global Hemoglobinopathy Market Worth US$ 788M by 2024 According to Persistence Market Research
Dentsu Announces its Corporate Venture Capital Fund Dentsu Ventures Investment in Grail
Xenex Receives Top Honors from Frost & Sullivan for LightStrike™ - the Only Pulsed Xenon UV Disinfection System in the Healthcare Market
Partners HealthCare and GE Healthcare Launch 10-year Collaboration to Integrate Artificial Intelligence into Every Aspect of the Patient Journey
US Acute Care Solutions Celebrates 2-Year Anniversary

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit RightITnow Ltd

Visit  MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)